Iq Life Sciences - Company Profile

It is a pharma private not for profit company based in New Delhi, Delhi, India, established in 2012.
2012 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Iq Life Sciences

Iq Life Sciences, a active private not for profit company, was established on 01 March 2012 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U73100DL2012NPL232269. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Pradeep Yohanne Gupta (Director), Raju Kanojia (Director). Past directors included Saroj Gupta, Raju Kanojia. Its latest AGM occurred on 20 August 2024, with the balance sheet filed on 31 March 2024. It is based at S-470, Greater Kailash-Ii,, New Delhi, Delhi, 110048.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100DL2012NPL232269

  • Registration Number

    232269

  • Incorporation Date

    01 March 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Profit Growth **** 19.70%
  • Ebitda **** 25.43%
  • Net Worth -39.28%
  • Total Assets -2.49%
Company report

Iq Life Sciences

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Iq Life Sciences — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Iq Life Sciences?
Current Directors
Name Designation Appointment Date Status
Pradeep Yohanne Gupta Director 01 Mar 2012 Current
Raju Kanojia Director 16 Nov 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Oct 2022 Past
Pramod Abcsdd Additional Director 23 Jun 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Iq Life Sciences.

Iq Life Sciences, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 19.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 39.28%.

Iq Life Sciences revenue growth over time
Iq Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -2.49%
*******
*******
*******
*******
Profit or Loss
*******
 19.70%
*******
*******
*******
*******
Net Worth
*******
 -39.28%
*******
*******
*******
*******
EBITDA
*******
 25.43%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Iq Life Sciences?

In 2023, Iq Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Iq Life Sciences?

Unlock and access historical data on people associated with Iq Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Iq Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iq Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Iq Life Sciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Iq Life Sciences last Annual general meeting of members was held on 20 Aug 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Iq Life Sciences has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.

  • Director Appointment

    The activity Raju Kanojia was appointed as a Director was appointed as a Director on 16 Nov 2022 & has been associated with this company since 3 years 5 months . was completed.

  • Director Appointment

    The activity Pradeep Yohanne Gupta was appointed as a Director was appointed as a Director on 01 Mar 2012 & has been associated with this company since 14 years 2 months . was completed.

  • Company Incorporation

    The activity Iq Life Sciences was registered on 01 Mar 2012 with Roc Delhi & aged 14 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Iq Life Sciences?

The CIN of Iq Life Sciences is U73100DL2012NPL232269.

Where is Iq Life Sciences headquartered?

Iq Life Sciences is headquartered at S-470, Greater Kailash-Ii,, New Delhi, Delhi, 110048.

When was Iq Life Sciences incorporated?

Iq Life Sciences was incorporated on 01 March 2012.

Who are the current directors of Iq Life Sciences?

The current directors of Iq Life Sciences are

What is the primary industry of Iq Life Sciences?

The primary industry of Iq Life Sciences is Pharma.

Is Iq Life Sciences a listed company?

Iq Life Sciences is unlisted.

What is the capital structure of Iq Life Sciences?

The authorized capital of Iq Life Sciences is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Iq Life Sciences?

The compliance status of Iq Life Sciences is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available